Study startup delays often stem from challenges in building and validating EDC databases—but where do the biggest bottlenecks occur? In this post, we break down the most common EDC database build issues that slow study startup and share practical insights to help teams accelerate timelines while maintaining data quality and compliance.
The biggest bottlenecks, or “barriers” to speed and delivery of an EDC database occur when there is uncertainty about what data needs to be collected for the protocol. Below are three very common bottlenecks that SDC sees when beginning an EDC build with a study sponsor.
Our team will start discussions with the sponsor to build the appropriate case report form (CRF), but it’s not uncommon for a clinical team to request multiple amendments to a CRF before deciding on the final version. This can be an unnecessarily lengthy process if the right stakeholders with the right expertise are not engaged early.
A second area where we see bottlenecks is when data point definition begins too early—before the final protocol is approved. If the protocol is still in revision while teams are trying to determine data collection requirements, it creates a challenging dynamic. Protocol complexity can vary greatly, and while flexibility is important, repeated protocol amendments during database implementation can significantly impact timelines.
A third common bottleneck is how and when key inputs are provided by sponsors and study teams. In many cases, requirements are delivered in a piecemeal fashion rather than as a cohesive set of finalized inputs. Additionally, key opinion leaders (KOLs) or subject matter experts (SMEs) may have limited availability for upfront review, which can delay alignment. When feedback is introduced later in the process, it often results in additional revisions. In some instances, this feedback includes exploratory or non-protocol-driven data points that were not part of the original study design. While valuable in theory, these additions can increase complexity, extend build timelines, and introduce effort around data that may ultimately not be analyzed.
The ideal process begins with a finalized protocol, alignment on CRF design, then proceeds with database development, and sharing a working version of the database with appropriate stakeholders (SDC, sponsor, clinical teams, etc.) for structured review and feedback.
We have also found that having an experienced clinical programmer, database architect, or clinical data manager demonstrate the database and its functionality to the sponsor and their stakeholders is incredibly helpful in building alignment and trust. When teams can interact with the system directly, it provides far more clarity than reviewing specifications alone and typically leads to more consolidated, actionable feedback—ultimately helping to reduce rework and accelerate delivery.
Certainly, you can. The database really isn't a requirement to enroll a subject.
I have seen some sites use database readiness as a milestone to drive their ability to begin trial participation, but generally, that’s more of a misconception. Sites can enroll and treat patients, administer according to the protocol, and collect information in their source documents. Their source documents are not the database—in most cases, sites are not entering data directly into the EDC system as the source—they’re collecting that information first and transcribing it later.
That said, there is an important exception. If the study design includes randomization, then the functionality required to support that process needs to be in place prior to enrolling the first patient. That means having the initial enrollment forms, stratification inputs (if applicable), and the randomization module available and validated so patients can be appropriately assigned per protocol.
Admittedly, it isn’t ideal to not have a database ready before patient enrollment because you don’t want a backlog of data entry in the current landscape where teams want access to data as quickly as possible. In some cases, teams will move forward with what we call a “split build” approach—delivering the minimum necessary functionality (such as enrollment and randomization) while completing the rest of the database in parallel. This can work, but it often introduces additional regression testing and can create unnecessary risk if changes impact previously completed components.
That said, a site can still enroll a patient, begin data collection, conduct screening, and perform site visits. The best practice is to collect data per the protocol. Sites know the protocol, their patients, visit schedules, and required assessments. If they collect data according to the protocol, they have everything they will ultimately need for that final database.
Then, if the database is implemented shortly thereafter, it’s unlikely to interrupt data integrity.
One of the things that makes the SDC team so effective is our ability to be flexible, nimble, and responsive to necessary changes. Clinical trials can be complex, and we can’t always anticipate the patient experience.
With very complex protocols—such as those in rare disease or oncology—we expect revisions. The challenge is managing timelines around those revisions and helping clients understand the impact. At SDC, we try to anticipate where those changes are most likely to occur and design the database with that flexibility in mind. For example, leveraging more configurable approaches—such as custom functions in Rave versus more rigid, native configurations—allows us to better accommodate expected adjustments without introducing unnecessary rework.
We always keep a sharp eye on timelines, with the objective of reaching 98% database finality and allowing a small margin for controlled revisions.
This is a common question that we get asked, and the short answer is that “it depends.”
Most data management experts will tell you that a traditional EDC build takes anywhere from 8–12 weeks, but there are always outliers—some can be completed in as little as 2 weeks, while others may extend beyond 16 weeks depending on complexity and alignment.
It’s important to note that these timelines are most typical when working with a new client or study team, where there is naturally more time spent aligning expectations, processes, and ways of working. Once we have an established relationship and a deeper understanding of a client’s standards, specifications, and review approach, we can often reduce build timelines by 10–20% by leveraging that familiarity and reusing foundational components.
We will also address some of the newer claims around AI-driven acceleration later in this blog, but for now, these ranges represent a realistic baseline for traditional builds and engagements.
Below are two examples:
Example #1 -
When a client recently faced an aggressive timeline, we partnered closely to deliver a full MedNet EDC build in just under 6 weeks—providing a compliant, fully configured system that kept their study moving forward without compromise.
Example #2 -
For a more complex initial oncology study, getting a database into production can take up to 12 weeks, including development of the edit specifications. For subsequent studies with the same client, timelines are often shorter if we are able to build on prior work and because we already understand their specifications, collaboration model, and reporting needs.
Sponsors really like seeing the right therapeutic indication in their team’s background; however, from a data management perspective, that is often less important than the team leader’s strength in diplomacy and consensus-building while driving the technical process.
We place a strong emphasis on soft skills—particularly situational awareness and the ability to navigate complex team dynamics. Clinical study teams are cross-functional, and aligning stakeholders with different priorities requires a thoughtful, measured approach. Equally important is the ability to clearly communicate technical concepts to non-technical team members. Whether it’s explaining database design decisions, edit checks, or downstream impacts, that clarity is critical to keeping teams aligned and projects moving forward.
In the end, our goal is to deliver a database that reflects everyone’s input and is aligned with the study’s objectives and expectations.That said, therapeutic area experience can certainly help reduce communication barriers and accelerate understanding, especially in more complex studies. But ultimately, the most effective teams are those that can balance technical expertise with strong interpersonal skills.
Artificial Intelligence (AI) is rapidly transforming how EDC databases are designed, built, and deployed, with many vendors positioning it as a way to significantly compress traditional build timelines. The most impactful trends generally fall into a few key areas:
Protocol-to-build automation (AI-generated study design)
One of the most talked-about advancements is the ability to convert study protocols directly into EDC builds using AI. These tools aim to interpret inclusion criteria, visit schedules, and endpoints to generate CRFs, edit checks, and database structures.
While promising, the reality is that study protocols are often highly complex documents. It’s not uncommon to see inconsistencies between the main body of the protocol and the Schedule of Events, along with numerous footnotes, exceptions, and repeated visit or cycle structures. These nuances require interpretation and judgment, which can be difficult for AI to consistently manage in a fully automated way.
As a result, even with automation, significant review and refinement are still required to ensure the database accurately reflects study intent.
Predictive Form Design and Reusable Libraries
Many EDC systems now leverage AI trained on historical study builds to recommend form structures, edit checks, and standards. This can be highly effective in environments where there is a large volume of prior studies to draw from, which can help with:
Suggested CRFs and edit checks based on study type and prior builds
Increased reuse and standardization to reduce rework
Alignment to CDISC standards to streamline downstream processes
That said, for sponsors who are newer to EDC builds, or who do not yet have a robust library of prior studies, that benefit can be more limited. Vendor-provided standards can help a degree, but they often require tailoring to fit the specifics of a given protocol. In these cases, expectations around fully “ready-built” or validated study designs in just a few days should be approached with some caution.
Streamlining Edit Checks and Validation
Edit check development and validation has traditionally been one of the more time-intensive aspects of an EDC build. AI-driven recommendations can help identify common data patterns and inconsistencies, reducing some of the manual programming and iterative QA effort.
While this is very promising, it also places greater emphasis on the quality of the underlying requirements. Automated testing and validation will perform against those specifications as written—so if requirements are incomplete, inconsistent, or unclear, the system may validate successfully but still lead to downstream data collection or interpretation issues. As a result, thorough review and alignment on requirements upfront becomes even more critical to ensure that efficiency gains do not come at the expense of data quality.
AI-driven Data Monitoring and Standardization after EDC Deployment
Beyond the build itself, AI-enabled tools are improving how studies are monitored and managed after go-live. With solutions like SDC Insights 2.0 with SDC Sidekick AI, teams can benefit from:
Real-time anomaly detection and query generation
Earlier identification of protocol deviations
Fewer late-stage corrections that can delay database lock
AI is also helping to reduce manual effort in downstream activities such as statistical programming and submission preparation through assisted data standardization.
Overall, while AI is introducing meaningful efficiencies across the lifecycle of an EDC build, it is best viewed as an accelerator to experienced teams rather than a complete replacement for clinical and data management expertise—particularly when working with complex protocols.
Talk to our team about streamlining your study build process and eliminating common bottlenecks. We can help you select, build, deploy, and manage your EDC system and manage your clinical trial data throughout your trial.
As March is Multiple Myeloma Month we spoke with two of SDC’s clinical data managers, Joanne Gonzalez, Senior Director, Data Management and Vanessa...
SDC leaders in biostatistics and clinical data management address the biggest mistakes clinical research sponsors and CRO's make with their...
Explore how SDC Clinical helps organizations enhance data governance in light of ICH E6 R3 revisions, ensuring compliance and strategic growth in...